Jamie Christensen - Jan 4, 2024 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role
EVP & Chief Scientific Officer
Signature
/s/ John Moriarty, Attorney-in-Fact
Stock symbol
MRTX
Transactions as of
Jan 4, 2024
Transactions value $
-$90,038
Form type
4
Date filed
1/5/2024, 05:34 PM
Previous filing
Jan 3, 2024
Next filing
Jan 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Sale -$90K -1.53K -0.96% $58.81 157K Jan 4, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 3, 2020.